SCIEX And Hepregen Announce Co-Marketing Agreement For Comprehensive Metabolite Identification Solution

FRAMINGHAM, Mass.& MEDFORD, Mass.--(BUSINESS WIRE)--SCIEX, a global innovator in life science analytical technologies and Hepregen Corporation, a leader in the development of next-generation, application-directed, cell-based in vitro assay products, today announced a Co-Marketing Agreement to deliver a new metabolite identification (Met ID) solution for drug metabolism scientists. From cell culture to interpretation, this solution provides an extensive view into in vitro data to enable researchers to generate, identify and analyze metabolites in one simple workflow. Customers are guided through the entire workflow, including report generation, with an easy-to-use software solution from start to finish.

Help employers find you! Check out all the jobs and post your resume.